Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marker Therapeutics (MRKR) Prepaid Assets (2016 - 2025)

Marker Therapeutics (MRKR) has disclosed Prepaid Assets for 11 consecutive years, with $841293.0 as the latest value for Q1 2025.

  • On a quarterly basis, Prepaid Assets fell 8.26% to $841293.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $841293.0, a 8.26% decrease, with the full-year FY2024 number at $483717.0, down 51.05% from a year prior.
  • Prepaid Assets was $841293.0 for Q1 2025 at Marker Therapeutics, up from $483717.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $2.8 million in Q2 2022 to a low of $483717.0 in Q4 2024.
  • A 5-year average of $1.9 million and a median of $2.0 million in 2021 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: increased 20.73% in 2021, then crashed 62.24% in 2024.
  • Marker Therapeutics' Prepaid Assets stood at $2.5 million in 2021, then dropped by 25.57% to $1.8 million in 2022, then tumbled by 46.57% to $988126.0 in 2023, then crashed by 51.05% to $483717.0 in 2024, then soared by 73.92% to $841293.0 in 2025.
  • Per Business Quant, the three most recent readings for MRKR's Prepaid Assets are $841293.0 (Q1 2025), $483717.0 (Q4 2024), and $1.2 million (Q3 2024).